A carregar...
Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D(2)) in women receiving chemotherapy for metastatic breast cancer: A feasibility trial
The vitamin D hormone, [1,25(OH)(2)D, calcitriol], inhibits proliferation and angiogenesis in breast cancer but its therapeutic use is limited by hypercalcemia. Synthetic analogs of 1,25(OH)(2)D that are less calcemic, such as paricalcitol (19-nor-1,25-Dihydroxyvitamin D(2)), are used to treat hyper...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3813563/ https://ncbi.nlm.nih.gov/pubmed/23760489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.24350 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|